EWA
ANAB icon

EverSource Wealth Advisors’s AnaptysBio ANAB Stock Holding History

EverSource Wealth Advisors’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.39K Sell
65
-838
-93% -$50.8K ﹤0.01% 3349
2026
Q1 		$50.1K Buy
903
+28
+3% +$1.51K ﹤0.01% 1882
2025
Q4 		$42.4K Sell
875
-90
-9% -$3.51K ﹤0.01% 1857
2025
Q3 		$29.5K Sell
965
-117
-11% -$2.69K ﹤0.01% 2070
2025
Q2 		$24K Buy
1,082
+1,040
+2,476% +$21.8K ﹤0.01% 2158
2025
Q1 		$781 Buy
42
+32
+320% +$534 ﹤0.01% 3317
2024
Q4 		$132 Buy
+10
New +$242 ﹤0.01% 3508

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

EverSource Wealth Advisors's ANAB Position: Q2 2026 in Review

EverSource Wealth Advisors reduced its AnaptysBio (ANAB) stake by 93% in Q2 2026, selling an estimated $50.8K and leaving 65 shares worth $4.39K. The position accounts for ﹤0.01% of the portfolio, ranked #3349.

EverSource Wealth Advisors first reported a position in ANAB in Q4 2024 and has held it in 7 quarters since. The position peaked at $50.1K in Q1 2026. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • EverSource Wealth Advisors held 65 shares of AnaptysBio worth $4.39K as of Q2 2026.
  • EverSource Wealth Advisors sold 838 AnaptysBio shares in Q2 2026, an estimated $50.8K.
  • AnaptysBio made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3349 holding.
  • EverSource Wealth Advisors first reported a position in AnaptysBio in Q4 2024 and has held it in 7 quarters since.
  • EverSource Wealth Advisors's AnaptysBio position peaked at $50.1K in Q1 2026.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.